SunOpta CEO marks the sale as a key point in transforming to concentrate on plant-based and healthy snack segments. The move is expected to boost margins, enable a more capital-efficient model, strengthen finances and pave way for attractive growth opportunities.
SunOpta股票讨论
• $Okta (OKTA.US)$ 收益反应上升了+15.8%
• $StoneCo (STNE.US)$ 收益反应上升了+12.9%
• $Turning Point Therapeutics (TPTX.US)$ Bristol Myers Squibb (BMY)将以每股76.00美元收购Turning Point Therapeutics;预计从2025年开始对非通用会计净收益有增值效果
• $Amylyx Pharmaceuticals (AMLX.US)$ +24.9%(获得AMX0035的PDUFA日期延期;计划于9月...
暂无评论